Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Endometrial Cancer Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024


 

Available formats:    

StumbleUponEmail

Global Endometrial Cancer Diagnostics Market

 

Type of Condition (Endometrioid Carcinoma, Serous Adenocarcinoma, Adenosquamous Carcinoma, Carcinomasarcoma), Type of Test (Hysteroscopy,  Endometrial Biopsy, Dilation and Curettage, Ultrasound, CT Scan, MRI), End user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Endometrial Cancer Diagnostics market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Endometrial Cancer Diagnostics Market

Endometrial Cancer is a most common form of uterine cancer as the endometrium is part of uterus. Endometrial cancer often called as uterine cancer. It is the most commonly diagnosed gynecologic cancer. Endometrial cancer forms when cells in inner lining of uterus (endometrium) begin to grow out of control.

 

Market Dynamics: Endometrial Cancer Diagnostics Market

Increase in the prevalence and incidence of endometrial cancer propels the growth of the endometrial cancer diagnostics market globally. As per the stats of American Cancer Society, in 2012, about 47,130 new cases of endometrial cases were diagnosed and 8010 women died because of it. Furthermore increase in awareness regarding uterine diseases, availability of various treatment options and early diagnostic options drives the growth of endometrial cancer diagnostics market globally. Moreover increase in healthcare expenditure, technological advancements and developments and advanced healthcare services also propels the market growth of endometrial cancer diagnostics globally. However, low accuracy rate in the results of diagnostic tests, high cost associated with the tests and treatments, adverse effects and lack of awareness about innovative technologies may hinder the growth of endometrial cancer diagnostics market globally.

 

Market Scope: Endometrial Cancer Diagnostics Market

Endometrial Cancer Diagnostics market is segmented based on the type of condition, type of test, end user and geographical regions

Based on the type of condition, the market is segmented into the following:

  • Endometrioid Carcinoma
  • Serous Adenocarcinoma
  • Adenosquamous Carcinoma
  • Carcinomasarcoma

Based on the type of test, the market is segmented into the following:

  • Hysteroscopy
  • Endometrial Biopsy
  • Dilation and Curettage
  • Ultrasound
  • CT Scan
  • MRI

Based on the end user, the market is segmented into the following:

  • Diagnostic Centers
  • Hospitals
  • Ambulatory Surgical Centers

Based on the geographical regions, the market is segmented into the following:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

 

Market Summary: Endometrial Cancer Diagnostics Market

Unlike breast and prostate cancer where screening tests are available to the general population endometrial cancer is most commonly diagnosed at endometrial biopsy in symptomatic patients. No generally applicable screening test is available. Among all test types hysteroscopy is most commonly recommended uterine cancer diagnostic test. According to American Cancer Society, in 2017, about 61380 new cases of uterine cancer were diagnosed and around 10,000 were dead.  According to WHO, developed regions such as North America and Europe registers greater incidence rate for endometrial cancer due to lifestyle changes adopted by women.

 

Regional Analysis:  Endometrial Cancer Diagnostics Market

Geographically, global Endometrial Cancer Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America Endometrial Cancer Diagnostics market and Europe Endometrial Cancer Diagnostics market is growing due to increase in the prevalence of  endometrial cancer cases,  high healthcare expenditure, well established healthcare infrastructure. Asia Pacific Endometrial Cancer Diagnostics market has a lucrative growth, which is attributed to increase health awareness about female hygiene due to rapid economic growth in the region. Latin America Endometrial Cancer Diagnostics market and Middle East and Africa Endometrial Cancer Diagnostics market driven by growing healthcare expenditure, rise in awareness among the people, growing economy of emerging countries.

 

Competition Assessment: Endometrial Cancer Diagnostics Market

Some of the players in the global Endometrial Cancer Diagnostics market include:

  • Abbott Laboratories (U.S)
  • Ariad Pharmaceuticals, Inc. (U.S)
  • Merck & Co., Inc. (U.S)
  • Becton, Dickinson & Co. (U.S)
  • Siemens Healthcare Inc. (Germany)
  • Hoffman-La Roche Ltd. (Switzerland)
  • GlaxoSmithKline Plc., etc. (UK)

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Abbott Laboratories (U.S)
  • Ariad Pharmaceuticals, Inc. (U.S)
  • Merck & Co., Inc. (U.S)
  • Becton, Dickinson & Co. (U.S)
  • Siemens Healthcare Inc. (Germany)
  • Hoffman-La Roche Ltd. (Switzerland)
  • GlaxoSmithKline Plc., etc. (UK)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553